Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

donor derived HIV-Specific T cells with non-escaped epitope targets

A preparation of ex vivo expanded donor-derived (DD) human immunodeficiency virus (HIV)-specific T cells (HSTs) with non-escaped epitope targets (NEETs), that can potentially be used to eliminate HIV-infected cells and eradicate HIV. Upon administration, DD HST-NEETs target and kill HIV-infected cells, thereby eradicating HIV. HST-NEETs recognize multiple conserved, non-escaped HIV epitopes and their common variants, which is important in killing latently infected cells and could reduce viral escape.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	DD HST-NEETs DD-HST-NEETs

donor derived HIV-Specific T cells with non-escaped epitope targets

Search NCI's Drug Dictionary